PHARMA INFLUENCERS | NEWSLETTERS | WEBINARS

C.E.L.forpharma

Off-Label Prescribing – A New Worry for the Pharmaceutical Industry

By Neil Grubert, market access specialist, analyst and author. EU Study on Off-Label Prescribing In recent years, the pharmaceutical industry has been concerned by the precedent set...

Recent Featured Articles

A Q&A Session with SpendEdge’s Thought Leader on the Current Pharmaceutical Industry Against the Backdrop of the Corona Virus Epidemic

LONDON--(BUSINESS WIRE)--SpendEdge, a leading procurement intelligence firm, has recently announced the completion of its latest Q&A article on the rising complexities and the ways...

Vifor Pharma acquires Priority Review Voucher

ST GALLEN, Switzerland--(BUSINESS WIRE)--Regulatory News: Vifor Pharma today announced that it has agreed to purchase a US Food and Drug Administration (FDA) priority review voucher...

Life Science Workforce Pipeline Sustainability Among Topics To Be Discussed at the MichBio BioTalent Summit

ANN ARBOR, Mich.--(BUSINESS WIRE)--MichBio, the Michigan Bioscience Industry Association, will hold a BioTalent Summit on March 16th focused on bringing together bio-industry stakeholders to...

Sensorion Receives Ethics Committee Approval to Include New Military Sites in SENS-401 Phase 2 study

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotech company which specializes in the development of novel therapies to restore, treat and...

Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia

MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients...